Medline ® Abstract for Reference 43
of 'Management of epilepsy and pregnancy'
43
TI
Oxcarbazepine concentrations during pregnancy: a retrospective study in patients with epilepsy.
AU
Christensen J, Sabers A, Sidenius P
SO
Neurology. 2006;67(8):1497.
We assessed the concentration of the oxcarbazepine metabolite 10-hydroxycarbazepine (MHD) in nine pregnancies among seven women before, during, and after pregnancy. The mean dose-corrected concentration of MHD was decreased during pregnancy (analysis of variance, p = 0.0016), being 72% (SD = 13%) in the first trimester, 74% (SD = 17%) in the second trimester, 64% (SD = 6%) in the third trimester, and 108% (SD = 18%) after pregnancy vs the dose-corrected concentration before pregnancy.
AD
Department of Clinical Pharmacology, Aarhus University Hospital, Norrebrogade 44, DK-8000 Aarhus C, Denmark. Jakob@farm.au.dk
PMID